Last reviewed · How we verify
NCT07262021
Visual Function of Enhanced Monofocal Intraocular Lenses
NA trial testing enhanced monofocal IOL in Cataract in 30 participants. Not yet recruiting.
1 November 2026
Quick facts
| Lead sponsor | Vienna Institute for Research in Ocular Surgery |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 December 2025 |
| Primary completion | 1 November 2026 |
| Estimated completion | 1 November 2027 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- enhanced monofocal IOL
- enhanced monofocal IOL
Conditions studied
- Cataract — all drugs for Cataract →
Sponsor
Vienna Institute for Research in Ocular Surgery
Who can join
Adults 21 to 105, any sex, with Cataract. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparison of the visual function of two enhanced monofocal intraocular lenses after cataract surgery
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07262021
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other Vienna Institute for Research in Ocular Surgery trials
Trials by the same sponsor.
- NCT06914817 — Brillouin Microscopy Used to Evaluate Corneal Mechanical Properties · NA · not yet recruiting
- NCT07297849 — Eyelid Closure in Keratometry · NA · recruiting
- NCT07390253 — Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration · active not recruiting
- NCT06607848 — Comparison of Two Non- Diffractive Extended Depth of Focus Intraocular Lenses · NA · recruiting
- NCT06358664 — Caffeine and Cataract After Pars Plana Vitrectomy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07262021 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vienna Institute for Research in Ocular Surgery
- Last refreshed: 3 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07262021.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing